Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Corplex Donepezil TDS at Different Body Locations
NCT03432195Phase 1Completed
- Sponsor
- Corium
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Corium. Primary endpoints: Area Under the Curve at 18 weeks and Maximum Plasma Concentration at 18 weeks. Started Jan 2018; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03432195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432195.